ArticleCell death & disease2019

The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors.

Maria Pia Abruzzese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.